Study of VX-509 in Rheumatoid Arthritis Subjects taking Methotrexate

Mise à jour : Il y a 5 ans
Référence : EUCTR2011-004419-22

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the efficacy of multiple doses of VX-509 when administered for 12 weeks in subjects with active RA on stable MTX therapy. To evaluate the safety and tolerability of multiple doses of VX-509 when administered for 12 weeks in subjects with active RA on stable MTX therapy.


Critère d'inclusion

  • Rheumatoid Arthritis